Industry News
Copper Depletion Therapy Keeps High-Risk Triple-Negative Breast Cancer At Bay
Feb 15, 2013
An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most difficult-to-treat forms of cancer -- high-risk triple-negative breast cancer. The median survival for metastatic triple-negative breast cancer patients is historically nine months... Read More
Comparison Of Tube And IV Feeding In Malnourished Pediatric Cancer Patients
Feb 15, 2013
About 60 percent of pediatric cancer patients experience malnourishment during treatment. At that point, patients and families have a choice: tube feeding or IV nutrition supplement... Read More
Growth Of Cancerous Liver Tumors Suppressed By Key Molecule
Feb 15, 2013
A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule is active in the cells that surround a tumor cell, this "tumor microenvironment" becomes less hospitable to cancer growth. When the molecule is deficient, cancer thrives... Read More
Gene Discovered That Suppresses Herpesviruses
Feb 15, 2013
Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) hide within the worldwide human population. While dormant in the vast majority of those infected, these active herpesviruses can develop into several forms of cancer... Read More
Bisphosphonate Treatment May Protect Bone From The Negative Effects Of Emerging Cancer Drugs
Feb 15, 2013
Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis. The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive... Read More
FOXC2 Vital To Epithelial-Mesenchymal Transition In Breast Cancer; FDA-Approved Drug Blocks Its Effect In Preclinical Studies
Feb 15, 2013
Protein central to cancer stem cell formation provides new potential target Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development... Read More
Anti-Copper Drug Might Prevent Organ Metastasis in Triple-Negative Breast Cancer
Feb 15, 2013
An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most difficult-to-treat forms of cancer -- high-risk triple-negative breast cancer. The median survival for metastatic triple-negative breast cancer patients is historically nine months... Read More
Mothers Cope With Child's Cancer Diagnosis With The Help Of Problem-Solving Training
Feb 15, 2013
A multi-site clinical trial including the University of Colorado Cancer Center shows that the benefit of Bright IDEAS problem-solving skills training goes beyond teaching parents to navigate the complex medical, educational, and other systems that accompany a child's diagnosis of cancer - the training also leads to durable reduction in mothers' levels of anxiety and symptoms of... Read More
Lung Cancer To Overtake Breast Cancer Among Women In Europe
Feb 14, 2013
Within the next decade lung cancer is predicted to be the main cause of cancer deaths in European women, according to a recent study published in the journal Annals of Oncology. Lung cancer has already become the main cause of cancer death among women in the UK and Poland, overtaking breast cancer... Read More
Rise In Lung Cancer Deaths Among European Women
Feb 14, 2013
Lung cancer is likely to overtake breast cancer as the main cause of cancer death among European women by the middle of this decade, according to new research published in the cancer journal Annals of Oncology [1]. In the UK and Poland it has already overtaken breast cancer as the main cause of cancer deaths in women. The study by researchers in Italy and Switzerland predicts that just over 1... Read More
Previous Page Next Page